Atrás
4
Rango del Día
$47.75
$49.34
Rango de 52 Semanas
$29.16
$59.68
Volumen
558,737
Promedio 50D / 200D
$51.14
/
$45.13
Cierre Anterior
$47.76
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -73.6 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 0.0 | 3.8 |
| Net Margin % | -5.4 | 3.9 |
| Rev Growth 5Y % | 5.5 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$62.00
+25.9%
Low: $55.00
High: $65.00
P/E Futuro
25.6
EPS Futuro
$1.92
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
870 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$7.01
$6.77 – $7.19
|
1.4 B | 1 |
| FY2029 |
$6.91
$6.67 – $7.08
|
1.3 B | 1 |
| FY2028 |
$5.19
$2.33 – $8.05
|
1.2 B | 2 |
Puntos Clave
Revenue grew 5.53% annually over 5 years — modest growth
Earnings declined -152.19% over the past year
Debt/Equity of 0.03 — conservative balance sheet
Generating 45.99M in free cash flow
PEG of 0.48 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.10%
Crecimiento
Revenue Growth (5Y)
5.53%
Revenue (1Y)8.63%
Earnings (1Y)-152.19%
FCF Growth (3Y)-35.49%
Calidad
Return on Equity
-0.01%
ROIC0.00%
Net Margin-5.36%
Op. Margin-5.13%
Seguridad
Debt / Equity
0.03
Current Ratio1.90
Interest Coverage0.00
Valoración
P/E Ratio
-73.56
P/B Ratio0.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.63% | Revenue Growth (3Y) | 8.79% |
| Earnings Growth (1Y) | -152.19% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.53% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 718.95M | Net Income (TTM) | -38.55M |
| ROE | -0.01% | ROA | 0.00% |
| Gross Margin | 89.63% | Operating Margin | -5.13% |
| Net Margin | -5.36% | Free Cash Flow (TTM) | 45.99M |
| ROIC | 0.00% | FCF Growth (3Y) | -35.49% |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 1.90 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -73.56 | P/B Ratio | 0.00 |
| P/S Ratio | 3.94 | PEG Ratio | 0.48 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.84B | Enterprise Value | -95.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 718.95M | 661.82M | 607.52M | 667.24M | 579.78M |
| Net Income | -38.55M | 73.87M | 1.32M | 60.71M | 53.42M |
| EPS (Diluted) | -0.68 | 1.32 | 0.02 | 1.04 | 0.98 |
| Gross Profit | 644.39M | 583.91M | 523.74M | 580.02M | 504.71M |
| Operating Income | -36.86M | 81.67M | -5.27M | 46.12M | 86.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.45T | 1.37B | 1.28B | 1.70B | 1.69B |
| Total Liabilities | 390.93B | 332.34M | 356.16M | 816.30M | 873.30M |
| Shareholders' Equity | 1.06T | 1.04B | 921.52M | 886.20M | 815.85M |
| Total Debt | 30.37B | 34.27M | 41.53M | 444.76M | 427.03M |
| Cash & Equivalents | 128.45B | 69.33M | 75.05M | 93.12M | 203.43M |
| Current Assets | 644.18B | 686.07M | 493.11M | 734.15M | 601.59M |
| Current Liabilities | 338.17B | 292.40M | 290.20M | 687.96M | 315.38M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#810 of 820
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026